Patel Sunil 4
4 · LIGAND PHARMACEUTICALS INC · Filed Nov 3, 2022
Insider Transaction Report
Form 4
Patel Sunil
Director
Transactions
- Disposition to Issuer
Common Stock
2022-11-01−1,004→ 28,820 total - Disposition to Issuer
Employee Stock Option (right to buy)
2022-11-01−4,340→ 0 totalExercise: $90.68Exp: 2032-06-10→ Common Stock (4,340 underlying)
Footnotes (2)
- [F1]Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.
- [F2]The stock option vests and is exercisable on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders following the grant date or (ii) on June 10, 2023.